Table 2.

Plasma concentrations of RLP-C, apo C-III, apo A-I, and HDL subpopulations at baseline by randomization group.

	Placebo	Estrogen	Estrogen+Progestin	P value
mg/dL
RLP-C	14.2 (±14.5)	12.5 (±9.1)	11.7 (±9.3)	0.42
Apo C-III	14.1 (±4.5)	14.3 (±5.8)	13.7 (±5.0)	0.66
HDL apo C-III	9.9 (±4.8)	9.78 (±3.4)	9.5 (±4.3)	0.68
Apo A-I	125 (±21)	125 (±17)	128 (±20)	0.55
HDL-C	43 (±12)	43 (±11)	46 (±14)	0.14
HDL supopulations
preβ1	23.5 (±9.8)	23.8 (±8.3)	22.3 (±8.3)	0.55
preβ2	2.1 (±1.4)	2.1 (±1.3)	2.3 (±1.1)	0.69
α1	12.5 (±8.8)	11.7 (±7.1)	13.8 (±8.8)	0.27
α2	37.1 (±10.9)	37.8 (±10.0)	38.8 (±10.1)	0.58
α3	38.3 (±9.5)	38.7 (±8.0)	38.0 (±8.7)	0.86
preα1	2.4 (±1.9)	2.3 (±2.2)	3.0 (±2.3)	0.05
preα2	4.1 (±1.9)	4.2 (±2.0)	4.7 (±2.2)	0.11
preα3	4.7 (±2.1)	4.8 (±1.8)	5.0 (±1.9)	0.29

values are mean (±SD)

HDL subpopulations expressed as mg/dL of total plasma apo A-I.